The Radiologist's Approach to Assessing Cancer Risk of Thyroid Nodul…

Penn Medicine

J. Langer

Less is More: Active Surveillance In Low-Risk Papillary Thyroid Canc…

Keck School of Medicine of USC

R. Michael Tuttle

ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Cancers"

2024 ASCO® Annual Meeting Insights Hub

N. Saba

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

ASCO® 2024 Summary: "News in Head&Neck Cancers"

2024 ASCO® Annual Meeting Insights Hub

P. Bossi

ESMO 2024 Summary: Head & Neck Cancer Take Home Messages

2024 ESMO Annual Meeting Insights Hub

P. Bossi

ESMO 2024 Summary: Head & Neck Cancer Highlights

2024 ESMO Annual Meeting Insights Hub

N. Saba

Year in Review: Precision Medicine

Vivek Subbiah

NOS ASCO® 2023 Review: Nasopharynx Cancer

Nebraska Oncology Society

E. Sherman

Is It Possible? Thyroglobulin as a Tumor Marker after Lobectomy for …

Keck School of Medicine of USC

T. Angell

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

Parathyroid Disease and Tumors

Yale Cancer Center

C. Gibson

Hypercalcaemia & Hypocalcaemia

Obafemi Awolowo University

D. Soyoye

ESMO 2024 Insights: 3-Weekly vs. Weekly Cisplatin in High-Risk HNSCC…

2024 ESMO Annual Meeting Insights Hub

M. Tahara

The Approach to a Patient with a Thyroid Nodule: Updating "The Bethe…

Penn Medicine

Z. Baloch

ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Trametinib …

Insights from 2023 ASCO® Annual Meeting

V. Subbiah

Too Much or Not Enough: When to Use Radioactive Iodine for Different…

Keck School of Medicine of USC

V. J. Bernet

Recent Advances in Treatment of Thyroid Cancer With Precision Medici…

Jefferson Health

M. Brose

ASCO® 2023 Summary: "Key H&N Cancer Studies Including FRAIL-IMMUNE &…

Insights from 2023 ASCO® Annual Meeting

P. Bossi

Thyroid Nodule Fine Needle Aspiration

Jefferson Health

J. Sheehan